These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3846306)

  • 21. [Importance of risk factors in myocardial infarction (author's transl)].
    Prachar H; Pollak H; Arnoldner O; Dittel M; Kiss E; Nobis H; Spiel R; Enenkel W
    Z Kardiol; 1980 Nov; 69(11):782-9. PubMed ID: 7467661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of physical activity in the prevention of degenerative heart and vascular diseases?].
    Mertz DP
    Dtsch Med Wochenschr; 1976 Feb; 101(6):214-5. PubMed ID: 765087
    [No Abstract]   [Full Text] [Related]  

  • 23. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study.
    Heidemann C; Hoffmann K; Klipstein-Grobusch K; Weikert C; Pischon T; Hense HW; Boeing H
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):65-71. PubMed ID: 17301629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Italian preventive trial of coronary heart disease: the Rome Project of Coronary Heart Disease Prevention.
    Menotti A
    Prog Biochem Pharmacol; 1983; 19():230-44. PubMed ID: 6828474
    [No Abstract]   [Full Text] [Related]  

  • 25. [The risk factors of coronary disease].
    Di Matteo J; Fleury G
    Rev Prat; 1974 Dec 7-11; 24(55):5059-60, 5065-6, 5069-71. PubMed ID: 4445779
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of heart disease in the young coronary candidate.
    Kannel WB
    Prim Care; 1977 Jun; 4(2):229-43. PubMed ID: 586715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF
    Arch Intern Med; 1993 Sep; 153(18):2085-92. PubMed ID: 8104394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of physical activity in disease prevention and treatment.
    Yeater RA; Ullrich IH
    W V Med J; 1985 Feb; 81(2):35-9. PubMed ID: 3883655
    [No Abstract]   [Full Text] [Related]  

  • 30. [Basic treatment of coronary atherosclerosis].
    Barrillon A; Binet JP; de Gennes JL; Hazan E; Lenègre J
    Presse Med (1893); 1969 Jun; 77(28):1013-6. PubMed ID: 5795147
    [No Abstract]   [Full Text] [Related]  

  • 31. Family-directed preventive cardiology.
    Davidson DM; Doyle EJ
    J Fam Pract; 1984 Jan; 18(1):57-64. PubMed ID: 6693848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutrition and diet. 4. Care of the post-coronary patient.
    Leslie J
    Nurs Mirror; 1977 Jul; 145(4):21-3. PubMed ID: 587377
    [No Abstract]   [Full Text] [Related]  

  • 33. Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: a failure of present management.
    Baskett RJ; Buth KJ; Collicott C; Ross DB; Hirsch GM
    Can J Cardiol; 2002 Apr; 18(4):397-402. PubMed ID: 11992133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity as prevention and therapy in coronary heart disease.
    Sanne HM; Wilhelmsen L
    Scand J Rehabil Med; 1971; 3(1):47-56. PubMed ID: 4949733
    [No Abstract]   [Full Text] [Related]  

  • 35. [Distribution and treatment of cardiovascular risk factors in coronary patients: the Prevenir Study].
    Marques-Vidal P; Cambou JP; Ferrières J; Thomas D; Grenier O; Cantet C; Danchin N;
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):673-80. PubMed ID: 11494627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death.
    Zotz RB; Klein M; Dauben HP; Moser C; Gams E; Scharf RE
    Thromb Haemost; 2000 Mar; 83(3):404-7. PubMed ID: 10744144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family history, cigarette smoking and other risk factors in patients with myocardial infarction.
    Woodhouse SP; Restieaux NJ; Ablett MB; Amarasingham R; Smith BR
    N Z Med J; 1981 Dec; 94(698):443-7. PubMed ID: 6950289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypertension and coronary heart disease. Global risk moderation through control of body weight].
    Suter PM; Häsler E; Vetter W
    Praxis (Bern 1994); 1996 Jan; 85(5):113-6. PubMed ID: 8643904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intervention in ischemic heart disease and myocardial infarction. 1. Intervention via risk factors].
    Pedersen A; Schroll M
    Ugeskr Laeger; 1982 Jul; 144(29):2139-46. PubMed ID: 6755844
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug prevention of coronary disease].
    Miettinen TA
    Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.